BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 33744686)

  • 41. Expression and localization of ecto-nucleotide pyrophosphatase/phosphodiesterase I-1 (E-NPP1/PC-1) and -3 (E-NPP3/CD203c/PD-Ibeta/B10/gp130(RB13-6)) in inflammatory and neoplastic bile duct diseases.
    Yano Y; Hayashi Y; Sano K; Nagano H; Nakaji M; Seo Y; Ninomiya T; Yoon S; Yokozaki H; Kasuga M
    Cancer Lett; 2004 Apr; 207(2):139-47. PubMed ID: 15072822
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Discovery of novel pyrrolopyrimidine/pyrazolopyrimidine derivatives bearing 1,2,3-triazole moiety as c-Met kinase inhibitors.
    Wang L; Liu X; Duan Y; Li X; Zhao B; Wang C; Xiao Z; Zheng P; Tang Q; Zhu W
    Chem Biol Drug Des; 2018 Jul; 92(1):1301-1314. PubMed ID: 29575727
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Highly Potent and Selective Ectonucleoside Triphosphate Diphosphohydrolase (ENTPDase1, 2, 3 and 8) Inhibitors Having 2-substituted-7- trifluoromethyl-thiadiazolopyrimidones Scaffold.
    Afzal S; Zaib S; Jafari B; Langer P; Lecka J; Sévigny J; Iqbal J
    Med Chem; 2020; 16(5):689-702. PubMed ID: 31203806
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel 5,6-disubstituted pyrrolo[2,3-d]pyrimidine derivatives as broad spectrum antiproliferative agents: Synthesis, cell based assays, kinase profile and molecular docking study.
    Lee JH; El-Damasy AK; Seo SH; Gadhe CG; Pae AN; Jeong N; Hong SS; Keum G
    Bioorg Med Chem; 2018 Nov; 26(21):5596-5611. PubMed ID: 30385226
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quinazoline-4-piperidine sulfamides are specific inhibitors of human NPP1 and prevent pathological mineralization of valve interstitial cells.
    Shayhidin EE; Forcellini E; Boulanger MC; Mahmut A; Dautrey S; Barbeau X; Lagüe P; Sévigny J; Paquin JF; Mathieu P
    Br J Pharmacol; 2015 Aug; 172(16):4189-99. PubMed ID: 26031197
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Design, synthesis and evaluation of novel 2-(1H-imidazol-2-yl) pyridine Sorafenib derivatives as potential BRAF inhibitors and anti-tumor agents.
    Jiao Y; Xin BT; Zhang Y; Wu J; Lu X; Zheng Y; Tang W; Zhou X
    Eur J Med Chem; 2015 Jan; 90():170-83. PubMed ID: 25461318
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diadenosine 5',5''-(boranated)polyphosphonate analogues as selective nucleotide pyrophosphatase/phosphodiesterase inhibitors.
    Eliahu S; Lecka J; Reiser G; Haas M; Bigonnesse F; Lévesque SA; Pelletier J; Sévigny J; Fischer B
    J Med Chem; 2010 Dec; 53(24):8485-97. PubMed ID: 21090681
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of adenine-N9-(methoxy)ethyl-β-bisphosphonate as NPP1 inhibitor attenuates NPPase activity in human osteoarthritic chondrocytes.
    Nassir M; Arad U; Lee SY; Journo S; Mirza S; Renn C; Zimmermann H; Pelletier J; Sévigny J; Müller CE; Fischer B
    Purinergic Signal; 2019 Jun; 15(2):247-263. PubMed ID: 31025169
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Design, synthesis, and antiproliferative activity of new 1H-pyrrolo[3,2-c]pyridine derivatives against melanoma cell lines.
    El-Gamal MI; Jung MH; Lee WS; Sim T; Yoo KH; Oh CH
    Eur J Med Chem; 2011 Aug; 46(8):3218-26. PubMed ID: 21592628
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis and Anticancer Activity of 3-(Substituted Aroyl)-4-(3,4,5-trimethoxyphenyl)-1H-pyrrole Derivatives.
    Zhan XP; Lan L; Wang S; Zhao K; Xin YX; Qi Q; Wang YL; Mao ZM
    Chem Biodivers; 2017 Feb; 14(2):. PubMed ID: 27696660
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and biological evaluation of curcumin inspired imidazo[1,2-a]pyridine analogues as tubulin polymerization inhibitors.
    Ramya PVS; Guntuku L; Angapelly S; Digwal CS; Lakshmi UJ; Sigalapalli DK; Babu BN; Naidu VGM; Kamal A
    Eur J Med Chem; 2018 Jan; 143():216-231. PubMed ID: 29174816
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacophore-based virtual screening, synthesis, biological evaluation, and molecular docking study of novel pyrrolizines bearing urea/thiourea moieties with potential cytotoxicity and CDK inhibitory activities.
    Shawky AM; Ibrahim NA; Abourehab MAS; Abdalla AN; Gouda AM
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):15-33. PubMed ID: 33103497
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design, synthesis and biological evaluation of novel pyridine-thiazolidinone derivatives as anticancer agents: Targeting human carbonic anhydrase IX.
    Ansari MF; Idrees D; Hassan MI; Ahmad K; Avecilla F; Azam A
    Eur J Med Chem; 2018 Jan; 144():544-556. PubMed ID: 29289880
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 1H-pyrrolo[2,3-b]pyridine: A new scaffold for human neutrophil elastase (HNE) inhibitors.
    Crocetti L; Giovannoni MP; Schepetkin IA; Quinn MT; Khlebnikov AI; Cantini N; Guerrini G; Iacovone A; Teodori E; Vergelli C
    Bioorg Med Chem; 2018 Nov; 26(21):5583-5595. PubMed ID: 30385225
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis of 2-substituted Furo[3,2-b]pyridines Under Pd/C-Cu Catalysis Assisted by Ultrasound: Their Evaluation as Potential Cytotoxic Agents.
    Laxmi DS; Vardhini SV; Guttikonda VR; Rao MVB; Pal M
    Anticancer Agents Med Chem; 2020; 20(8):932-940. PubMed ID: 32160853
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Subcellular targeting and function of osteoblast nucleotide pyrophosphatase phosphodiesterase 1.
    Vaingankar SM; Fitzpatrick TA; Johnson K; Goding JW; Maurice M; Terkeltaub R
    Am J Physiol Cell Physiol; 2004 May; 286(5):C1177-87. PubMed ID: 15075217
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors.
    Abdullaziz MA; Abdel-Mohsen HT; El Kerdawy AM; Ragab FAF; Ali MM; Abu-Bakr SM; Girgis AS; El Diwani HI
    Eur J Med Chem; 2017 Aug; 136():315-329. PubMed ID: 28505536
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Specificity of the ecto-ATPase inhibitor ARL 67156 on human and mouse ectonucleotidases.
    Lévesque SA; Lavoie EG; Lecka J; Bigonnesse F; Sévigny J
    Br J Pharmacol; 2007 Sep; 152(1):141-50. PubMed ID: 17603550
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pyrrolo[2,3-b]pyridine-3-one derivatives as novel fibroblast growth factor receptor 4 inhibitors for the treatment of hepatocellular carcinoma.
    Jin Q; Zhang D; Gao M; Jiang C; Zhang J
    Bioorg Med Chem; 2021 Jan; 29():115862. PubMed ID: 33218898
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Design, synthesis, molecular modeling and biological evaluation of novel 1H-pyrazolo[3,4-b]pyridine derivatives as potential anticancer agents.
    Eissa IH; El-Naggar AM; El-Hashash MA
    Bioorg Chem; 2016 Aug; 67():43-56. PubMed ID: 27253830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.